Culver Cheung

Culver Cheung is an experienced professional in formulation development and drug product development, currently serving as the Director of Formulation Development at MapLight Therapeutics, Inc., a position held since October 2022. Prior roles include Associate Director of Formulation Development at the same company and Principal Scientist in Drug Product Development at Akebia Therapeutics from June 2018 to October 2022. Additional experience encompasses positions at Tetraphase Pharmaceuticals, Infinity Pharmaceuticals, and Alkermes, where responsibilities ranged from Scientist to Process Development Engineer. Culver Cheung holds a Master of Science in Biotechnology from Northeastern University and a Bachelor of Science in Chemical Engineering from the University of Massachusetts Amherst.